CPHI & PMEC China (24-26 Juni) kembali digelar di Shanghai New International Expo Center setelah semakin diminati di pasar ...

Penemuan baru dari Stasiun Luar Angkasa China itu adalah satu bakteri baru yang tidak ada di bumi, namun adanya hanya di luar ...

Mikroba aerobik baru ditemukan dari Stasiun Luar Angkasa Tiangong milik China. Makhluk ini mampu bertahan pada lingkungan ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Indrayani, operator Siskohat Toraja Utara, naik haji usai 11 tahun menanti. Momen makin istimewa setelah ia dilantik sebagai PPPK dua hari sebelumnya ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

TRIBUNTORAJA.COM - Indrayani Umar Muchlas berbahagia. Setelah 11 tahun menanti, niatnya menunaikan ibadah haji akhirnya terwujud. Tergabung dalam Kloter 37, Indrayani satu dari 19 Jamaah Calon Haji (J ...

Tucson-based biotech firm HTG Molecular Diagnostics has filed for Chapter 11 bankruptcy protection, with plans to continue operations as it works out a plan to pay its debts. The company ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...

Hyperspectral reporters allow bacteria on the ground to be imaged by high-flying drones, expanding environmental monitoring to large outdoor areas. Producing goods, such as foods and fuels, with ...

Investment group Atlas Ventures has closed its fourteenth fund, raising $450 million for the next round of investment in biotech start-ups. Fund XIV comes two years after Atlas' last fund and will ...